Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs (Q38422203)
Jump to navigation
Jump to search
scientific article published on January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs |
scientific article published on January 2012 |
Statements
1 reference
Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs (English)
1 reference
Michelle Hottinger
1 reference
Bryan A Liang
1 reference
1 January 2012
1 reference
1 reference
38
1 reference
4
1 reference
667-689
1 reference
Identifiers
1 reference
1 reference